Clearstead Advisors’s Biomea Fusion BMEA Stock Holding History

Clearstead Advisors’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-293	Closed	-$528	–	3113
2025 Q2	$528	Buy	+293	New	+$564	﹤0.01%	2484

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Clearstead Advisors's BMEA Position: Q3 2025 in Review

Clearstead Advisors sold out of Biomea Fusion (BMEA) in Q3 2025, closing a stake of 293 shares — an estimated $528 sold.

Clearstead Advisors first reported a position in BMEA in Q2 2025 and held it in 1 quarter. The position peaked at $528 in Q2 2025. 73 funds tracked by Wall St. Rank hold BMEA as of Q3 2025.

Clearstead Advisors reported no remaining Biomea Fusion position as of Q3 2025 after selling out during the quarter.
Clearstead Advisors sold 293 Biomea Fusion shares in Q3 2025, an estimated $528.
Clearstead Advisors first reported a position in Biomea Fusion in Q2 2025 and held it in 1 quarter.
Clearstead Advisors's Biomea Fusion position peaked at $528 in Q2 2025.
73 funds tracked by Wall St. Rank held Biomea Fusion as of Q3 2025.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.